Nutritional Supplement NutriLife AR1 May be Answer for Cancer Patients
NutriLife AR1, an all-natural nutritional supplement, has shown documented improvement in patients with various forms of cancer and other types of illness when taken regularly.
(PRWEB) December 20, 2004 -- NutriLife AR1 (AR1) is an all-natural nutritional supplement made from a unique processing of
fermented wheat, corn, and soybean grains discovered in Brazil. More than 20
years of testing the nutritional
supplement with cancer patients, including terminal cases, had extraordinary
results, including reducing the size and slowing the growth of tumors and
cancerous cells, causing much fewer side effects in patients under chemotherapy
and radiation, and essentially improving the quality of life.
“Current
medicine tries to treat cancer patients using toxic drugs, radiation, or radical
surgery in order to remove or to kill cancer cells,” said Dr. Quivo S. Tahin,
founder of the Ultimate Health Consortium. “On the other hand, several popular
‘home made’ products and procedures that have been used for decades claim to be
able to help curing cancer. These products are now being used seriously in what
is known as Alternative Medicine.”
All the information and documented
results show that the AR1 nutritional
supplement appears to have the ability to repair the DNA damaged during the
progression of the carcinogenesis and to stimulate self-healing by enhancing the
immune system. It has also been reported that AR1 has helped people with
infections, arthritis and rheumatism, and AIDS.
The NutriLife AR1 nutritional supplement has recently become available in the
United States after treating people in Brazil with positive results for over
twenty years. In the last few months, NutriLife AR1 has received several
documented positive results from Americans taking the nutritional supplement.
V.C., a man in his early
fifties, was diagnosed with a brain tumor and confined to bed in late 2002.
After taking AR1 for two weeks, he was able to drive himself to his doctor for
his radiation treatment. Bonnie Armstrong, a Pennsylvanian woman in her forties,
is a secretary with arthritis in both her hands. She began taking AR1 in May
2003, and after only three days, she felt so relieved that she is now
recommending the nutritional supplement for everyone.
“We believe with
the help of the proper nutritional supplements, the human immune system has the
ability to accelerate healing,” said Dr. Quivo S. Tahin. This is why NutriLife
AR1 also recommends the nutritional supplement for AIDS and HIV-positive
patients—to improve their energy and to enhance their immune system. AR1
nutritional supplements may also help patients tolerate toxic medical treatments
like chemotherapy and radiation.
To see the nutritional facts for AR1 or
to read one of the many free articles available about the nutritional
supplement, visit http://www.ultimatehealthconsortium.com/. NutriLife AR1 is
available for purchase on the website or by calling 215-673-1399.
About
NutriLife AR1
This nutritional supplement was discovered in Brazil by a
pharmacist more than twenty years ago. He discovered this product through a
fungus fermentation of wheat, corn, and soy bean proteins. He started to give
this product to cancer patients, many of them terminal cases. Extraordinary
successes occurred, actually curing some of the cancer in a relatively short
time period. After his death, his children decided to manufacture this product,
now named AR1. It is considered to be a nutritional supplement, but has been
reported to be an excellent aid for the treatment of almost all types of cancer,
and of severe infection.
These statements have not been evaluated by the
U.S. Food & Drug Administration. This product is not intended to diagnose,
treat, cure, or prevent disease. NutriLife AR1 is not making any medical claims,
nor are they suggesting the use of this product as a remedy or treatment for
illnesses. Patented product manufactured in Brazil by SANDEX IND. QUIM. FARM.
Lda., MG, Brazil.
Press Release Advertising
powered by Xeal Inc.
# # #
Source : http://www.prweb.com/releases/2004/12/prweb190195.htm